Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Masimo Corporation | MASI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 134.32 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 134.32 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 75.22 - 196.83 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 134.32 | USD |
Masimo (MASI) Options Flow Summary
Masimo Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 7.11B | 52.91M | - | 2.05B | 81.5M | 1.54 | 87.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Masimo News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MASI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 138.11 | 138.99 | 133.52 | 136.07 | 271,996 | -3.79 | -2.74% |
| 1 Month | 139.43 | 147.89 | 133.52 | 141.08 | 433,017 | -5.11 | -3.66% |
| 3 Months | 128.44 | 153.93 | 120.85 | 134.83 | 531,243 | 5.88 | 4.58% |
| 6 Months | 81.74 | 153.93 | 75.36 | 112.70 | 718,840 | 52.58 | 64.33% |
| 1 Year | 196.03 | 196.83 | 75.22 | 117.20 | 773,074 | -61.71 | -31.48% |
| 3 Years | 244.89 | 305.21 | 75.22 | 147.85 | 635,569 | -110.57 | -45.15% |
| 5 Years | 124.02 | 305.21 | 75.22 | 163.20 | 536,862 | 10.30 | 8.31% |
Masimo Description
| Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (67% of 2020 sales), followed by Europe, the Middle East, and Africa (21%), Asia and Australia (9%), and North and South America excluding the U.S. (3%). |
